Proposed pulsed NADH therapy for cancer and aging: a conceptual framework
This abstract proposes, but does not test, brief intense pulses of reducing equivalents such as NADH, combined with glucose restriction and magnesium optimization, as a joint anti-cancer and anti-aging strategy. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract states that oncology aims to deplete NAD+ in cancer cells, while anti-aging medicine gives NAD+ intravenously to restore age-related declines. [1]
The author proposes pulsed exogenous reducing equivalents, mainly NADH, as an integrated anti-cancer and anti-aging strategy, arguing cancer cells cannot dispose of acute NADH excess. [1]
The proposed protocol combines brief intense pulses with recovery phases, glucose restriction and intracellular magnesium optimization; a speculative appendix addresses quantum biology. [1]
The source at a glance
- Study type / format
- Conceptual proposal (abstract only)
- Population / context
- Cancer cells and healthy cells as described conceptually; no human or animal participants reported.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- April 3, 2026
Proposed NADH pulses versus current NAD strategies
The abstract states that NAD+ metabolism is central to both tumor development and cellular aging. It notes that current strategies pull in opposite directions: oncology aims to deplete NAD+ in cancer cells, while anti-aging medicine gives NAD+ intravenously to restore levels that decline with age. The author proposes instead the pulsed administration of exogenous reducing equivalents, with NADH as the main but not only vehicle, as an integrated anti-cancer and anti-aging approach.
Supporting source [1]
Rationale: assumed metabolic difference between cancer and healthy cells
The rationale rests on an assumed metabolic selectivity. Cancer cells, described as having mitochondrial dysfunction and dependence on fermentative glycolysis (the Warburg effect), would be unable to dispose of an acute NADH excess through the electron transport chain and would therefore suffer selectively lethal reductive stress. Healthy cells with functional mitochondria would manage the overload by oxidizing excess NADH in the respiratory chain, with respiratory control regulating the flux. The abstract presents this as reasoning, not as measured results.
Supporting source [1]
Proposed protocol triad and speculative quantum appendix
The proposed protocol consists of brief, intense pulses (called a redox press-pulse) followed by recovery phases, combined with glucose restriction (ketogenic diet or fasting) and optimization of intracellular magnesium. This triad of reducing substrate, enzymatic structure and environment is intended to restore respiratory chain efficiency in healthy cells and selectively destabilize cancer cell metabolism. The abstract also discusses convergence between anti-cancer and anti-aging mechanisms via cyclic reductive impulses, and a speculative appendix explores quantum biology for mitochondrial electron transfer.
Supporting source [1]
How to interpret this
This is an abstract of a proposal; the full text was not reviewed. No experiments, participants, outcomes, effect sizes or safety data are reported, so the selective-killing rationale and the combined protocol remain untested hypotheses, not demonstrated benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Freschi M. · europepmc.org · April 3, 2026